Download PDFPDF

European Public Assessment Report (EPAR) summaries for the public: are they fit for purpose? A user-testing study
Compose Response

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g.
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Statement of Competing Interests


  • Responses are moderated before posting and publication is at the absolute discretion of BMJ, however they are not peer-reviewed
  • Once published, you will not have the right to remove or edit your response. Removal or editing of responses is at BMJ's absolute discretion
  • If patients could recognise themselves, or anyone else could recognise a patient from your description, please obtain the patient's written consent to publication and send them to the editorial office before submitting your response [Patient consent forms]
  • By submitting this response you are agreeing to our full [Response terms and requirements]

Vertical Tabs

Other responses

Jump to comment:

  • Published on:
    Response from the European Medicines Agency
    • Isabelle Moulon
    • Other Contributors:
      • Juan Garcia Burgos, Inga Abed, Paul Blake, Federica Castellani, Nacho Mbaeliachi and Marialuisa Spanu

    The European Medicines Agency (EMA) welcomes the research on the usability of the summaries of the European Public Assessment reports (EPAR summaries) by Professor David K Raynor and David Bryant recently published on the BMJ Open website.

    The EMA had first become aware of the results of this user-testing study in 2011 while the Agency was already consulting stakeholders on improving the EPAR summaries, aiming a...

    Show More
    Conflict of Interest:
    None declared.